These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 28534508)
41. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f). Cuesta R; Berman AY; Alayev A; Holz MK J Biol Chem; 2019 Feb; 294(7):2267-2278. PubMed ID: 30573685 [TBL] [Abstract][Full Text] [Related]
42. Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors. Muthukaruppan A; Lasham A; Woad KJ; Black MA; Blenkiron C; Miller LD; Harris G; McCarthy N; Findlay MP; Shelling AN; Print CG Clin Breast Cancer; 2017 Apr; 17(2):139-153. PubMed ID: 27756582 [TBL] [Abstract][Full Text] [Related]
43. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer. Tran N; Broun A; Ge K Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139 [TBL] [Abstract][Full Text] [Related]
44. Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways. Wang FS; Lian WS; Lee MS; Weng WT; Huang YH; Chen YS; Sun YC; Wu SL; Chuang PC; Ko JY J Mol Med (Berl); 2017 May; 95(5):499-512. PubMed ID: 28130569 [TBL] [Abstract][Full Text] [Related]
45. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Kawai H; Li H; Avraham S; Jiang S; Avraham HK Int J Cancer; 2003 Nov; 107(3):353-8. PubMed ID: 14506733 [TBL] [Abstract][Full Text] [Related]
46. Aberrant expression of SETD1A promotes survival and migration of estrogen receptor α-positive breast cancer cells. Jin ML; Kim YW; Jin HL; Kang H; Lee EK; Stallcup MR; Jeong KW Int J Cancer; 2018 Dec; 143(11):2871-2883. PubMed ID: 30191958 [TBL] [Abstract][Full Text] [Related]
47. The histone demethylase UTX/KDM6A in cancer: Progress and puzzles. Schulz WA; Lang A; Koch J; Greife A Int J Cancer; 2019 Aug; 145(3):614-620. PubMed ID: 30628063 [TBL] [Abstract][Full Text] [Related]
48. Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization. Kato H; Asamitsu K; Sun W; Kitajima S; Yoshizawa-Sugata N; Okamoto T; Masai H; Poellinger L Oncogene; 2020 Apr; 39(16):3322-3335. PubMed ID: 32071397 [TBL] [Abstract][Full Text] [Related]
49. Catalytic domain-dependent and -independent transcriptional activities of the tumour suppressor histone H3K27 demethylase UTX/KDM6A in specific cancer types. Sun W; Lee KL; Poellinger L; Masai H; Kato H Epigenetics; 2023 Dec; 18(1):2222245. PubMed ID: 37300822 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα. Ding J; Wang X; Zhang Y; Sang X; Yi J; Liu C; Liu Z; Wang M; Zhang N; Xue Y; Shen L; Zhao W; Luo F; Liu P; Cheng H Cancer Lett; 2019 Jan; 440-441():54-63. PubMed ID: 30315845 [TBL] [Abstract][Full Text] [Related]
51. PSF Promotes ER-Positive Breast Cancer Progression via Posttranscriptional Regulation of Mitobe Y; Iino K; Takayama KI; Ikeda K; Suzuki T; Aogi K; Kawabata H; Suzuki Y; Horie-Inoue K; Inoue S Cancer Res; 2020 Jun; 80(11):2230-2242. PubMed ID: 32213542 [TBL] [Abstract][Full Text] [Related]
52. UTX - moonlighting in the cytoplasm? Wiedemuth R; Thieme S; Navratiel K; Dorschner B; Brenner S Int J Biochem Cell Biol; 2018 Apr; 97():78-82. PubMed ID: 29421189 [TBL] [Abstract][Full Text] [Related]
53. FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index. Yau C; Meyer L; Benz S; Vaske C; Scott G; Egan B; Labhart P; Pourmand N; Benz CC Breast Cancer Res Treat; 2015 Nov; 154(1):23-32. PubMed ID: 26456572 [TBL] [Abstract][Full Text] [Related]
54. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448 [No Abstract] [Full Text] [Related]
55. A functional role for the histone demethylase UTX in normal and malignant hematopoietic cells. Liu J; Mercher T; Scholl C; Brumme K; Gilliland DG; Zhu N Exp Hematol; 2012 Jun; 40(6):487-98.e3. PubMed ID: 22306297 [TBL] [Abstract][Full Text] [Related]
57. Histone Demethylase UTX is an Essential Factor for Zygotic Genome Activation and Regulates Zscan4 Expression in Mouse Embryos. Bai L; Yang L; Zhao C; Song L; Liu X; Bai C; Su G; Wei Z; Li G Int J Biol Sci; 2019; 15(11):2363-2372. PubMed ID: 31595154 [TBL] [Abstract][Full Text] [Related]
58. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells. Sengupta S; Schiff R; Katzenellenbogen BS Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177 [TBL] [Abstract][Full Text] [Related]
59. MicroRNAs regulate KDM5 histone demethylases in breast cancer cells. Denis H; Van Grembergen O; Delatte B; Dedeurwaerder S; Putmans P; Calonne E; Rothé F; Sotiriou C; Fuks F; Deplus R Mol Biosyst; 2016 Feb; 12(2):404-13. PubMed ID: 26621457 [TBL] [Abstract][Full Text] [Related]
60. Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer. Hong Z; Li H; Li L; Wang W; Xu T Cancer Biomark; 2017; 18(2):125-131. PubMed ID: 27983522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]